Short Interest in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Rises By 16.5%

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 132,400 shares, an increase of 16.5% from the January 15th total of 113,600 shares. Currently, 0.6% of the shares of the stock are sold short. Based on an average trading volume of 184,500 shares, the short-interest ratio is presently 0.7 days.

Rapid Micro Biosystems Stock Down 2.5 %

Shares of Rapid Micro Biosystems stock traded down $0.09 on Monday, reaching $3.48. The company’s stock had a trading volume of 551,651 shares, compared to its average volume of 426,841. The company has a market capitalization of $149.76 million, a P/E ratio of -3.11 and a beta of 1.26. Rapid Micro Biosystems has a 52-week low of $0.58 and a 52-week high of $3.75. The stock has a 50-day moving average price of $1.50 and a 200-day moving average price of $1.13.

Wall Street Analyst Weigh In

Separately, KeyCorp assumed coverage on Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 target price on the stock.

Institutional Investors Weigh In On Rapid Micro Biosystems

A hedge fund recently bought a new stake in Rapid Micro Biosystems stock. Citadel Advisors LLC purchased a new position in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 72,024 shares of the company’s stock, valued at approximately $65,000. Citadel Advisors LLC owned about 0.17% of Rapid Micro Biosystems as of its most recent SEC filing. Institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.